On April 4th, CBD manufacturer Ispire went public on the NASDAQ Stock Exchange in the United States, issuing 2.7 million common shares at a price of $7.00 per share.
Laihe Biotech is a domestic enterprise in the plant extract industry, primarily engaged in the research and development, production, and sales of standardized plant extracts and high-purity active monomers.
The vaporization industry is an important downstream application area of industrial hemp. According to research data from Frost Sullivan, the global market size for electronic vaporization devices is expected to have an annual growth rate of 18.1% from 2018 to 2022 and is anticipated to maintain a growth rate of around 18.5% from 2022 to 2027.
Rhein Biotech has obtained the first public offering of shares by Ispire for distribution.
On April 7th, RAINBIO (Rhenium Biotech) released an announcement stating that the company used its own funds to acquire 214,285 shares of Ispire's (stock symbol "ISPR") initial public offering on the NASDAQ at a price of $7.00 per share, totaling $1,499,995. These newly issued shares became available for trading on the NASDAQ on April 4th, 2023.
Favorable for collaboration in the marijuana industry.
Rhine Biotech has announced its participation in Ispire's IPO strategic placement to deepen cooperation between the two companies in the industrial cannabis business. By combining their respective sales channels and resources, the companies hope to achieve mutually beneficial cooperation.
On its first day of trading, Ispire closed at $7.55, representing a 7.86% increase and a market capitalization of $400 million. As of now, the latest stock price is $7.00, and the latest market capitalization is $368.7 million.
Related Reading:
CBD manufacturer Ispire has successfully completed its initial public offering (IPO), raising a total of $18.9 million in funds.
CBD manufacturer Ispire has announced the pricing for its initial public offering (IPO): $7 per share for the issuance of 2.7 million shares.
References:
Rhine Biotech: Announcement Regarding the Acquisition of Shares Offered for Public Sale by Ispire and Initial Listing.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
